Sysmex ADR Income After Taxes 2016-2024 | SSMXY
Sysmex ADR annual/quarterly income after taxes history and growth rate from 2016 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Sysmex ADR income after taxes for the quarter ending December 31, 2024 was $0M, a 100% decline year-over-year.
- Sysmex ADR income after taxes for the twelve months ending December 31, 2024 was $0.194B, a 30.15% decline year-over-year.
- Sysmex ADR annual income after taxes for 2025 was $0.354B, a 7.27% increase from 2024.
- Sysmex ADR annual income after taxes for 2024 was $0.33B, a 2.58% decline from 2023.
- Sysmex ADR annual income after taxes for 2023 was $0.338B, a 13.74% decline from 2022.
| Sysmex ADR Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2025 | $354 |
| 2024 | $330 |
| 2023 | $338 |
| 2022 | $392 |
| 2021 | $298 |
| 2020 | $319 |
| 2019 | $370 |
| 2018 | $369 |
| 2017 | $361 |
| 2016 | $321 |
| Sysmex ADR Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | $70 |
| 2023-06-30 | $63 |
| 2022-06-30 | $62 |
| 2021-06-30 | $90 |
| 2020-06-30 | $41 |
| 2019-06-30 | $60 |
| 2018-06-30 | $86 |
| 2017-06-30 | $73 |
| 2016-06-30 | $88 |
| 2016-03-31 | $585 |
| 2015-12-31 | $524 |
| 2015-09-30 | $526 |
| 2015-06-30 | $478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.695B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $186.962B | 81.89 |
| Thermo Fisher Scientific (TMO) | United States | $155.018B | 18.75 |
| Edwards Lifesciences (EW) | United States | $45.151B | 29.60 |
| Alcon (ALC) | Switzerland | $43.193B | 29.19 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 49.02 |
| DexCom (DXCM) | United States | $33.204B | 51.32 |
| IQVIA Holdings (IQV) | United States | $27.457B | 15.38 |
| Mettler-Toledo (MTD) | United States | $24.791B | 29.48 |
| STERIS (STE) | Ireland | $23.645B | 26.04 |
| Waters (WAT) | United States | $20.829B | 29.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.814B | 0.00 |
| Hologic (HOLX) | United States | $14.322B | 15.56 |
| Penumbra (PEN) | United States | $9.806B | 76.97 |
| Masimo (MASI) | United States | $9.179B | 33.86 |
| Globus Medical (GMED) | United States | $7.878B | 18.77 |
| Glaukos (GKOS) | United States | $5.675B | 0.00 |
| Teleflex (TFX) | United States | $5.265B | 8.69 |
| TransMedics (TMDX) | United States | $4.349B | 94.54 |
| Integer Holdings (ITGR) | United States | $4.215B | 22.08 |
| PROCEPT BioRobotics (PRCT) | United States | $3.221B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 14.89 |
| Nihon Kohden (NHNKY) | Japan | $2.156B | 24.73 |
| Veracyte (VCYT) | United States | $2.071B | 29.07 |
| Elekta AB (EKTAY) | Sweden | $1.965B | 17.67 |
| Alphatec Holdings (ATEC) | United States | $1.643B | 0.00 |
| Artivion (AORT) | United States | $1.307B | 122.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.294B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.030B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.768B | 38.97 |
| SiBone (SIBN) | United States | $0.764B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.83 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.535B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.524B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.458B | 12.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.426B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.375B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.53 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EnVVeno Medical (NVNO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.85 |